Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Dr David Cutter

Dr David Cutter

Contact information


david.cutter@ndph.ox.ac.uk

David Cutter

MB, BChir (Cantab), MRCP, FRCR, DPhil

Associate professor, Consultant oncologist

David Cutter is a clinical oncologist and associate professor. He studied medicine at the University of Cambridge (1994-2000) and trained in Oncology at the Oxford Cancer Centre.

In 2008 he joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) to study for a DPhil on the late cardiovascular effects of cancer treatments. In 2013, he was appointed as a consultant clinical oncologist at the Oxford Cancer Centre and continues to work within Oxford Population Health as co-investigator on a Cancer Research UK research programme investigating the benefits and risks of cancer treatments.

He leads studies into the benefits and risks of lymphoma treatments, through a range of national and international collaborations, working within a multi-disciplinary team that includes epidemiologists, statisticians, medical physicists, other clinicians, patients and members of the public.

His overall aim is to provide high quality information to enable doctors and patients to make the best decisions regarding their individual lymphoma treatment and aftercare.